Elevate Uranium Stock Year To Date Return
| ELVUF Stock | USD 0.18 0.01 5.26% |
Elevate Uranium fundamentals help investors to digest information that contributes to Elevate Uranium's financial success or failures. It also enables traders to predict the movement of Elevate OTC Stock. The fundamental analysis module provides a way to measure Elevate Uranium's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Elevate Uranium otc stock.
Elevate |
Elevate Uranium OTC Stock Year To Date Return Analysis
Elevate Uranium's Year to Date Return (YTD) is the total return generated from holding a security from the beginning of the current fiscal year. In other words, YTD Return represents the capital appreciation of your investments from the start of the current fiscal year.
More About Year To Date Return | All Equity Analysis
YTD Return | = | (Mean of Monthly Returns - 1) | X | 100% |
Year-To-Date typically refers to a period starting from the beginning of the current year and continuing up to the present day. Investors should becareful when comparing YTD ratios if not much of the year has occurred as research shows that YTD measures are more sensitive to early periods than late.
| Competition |
According to the company's disclosures, Elevate Uranium has a Year To Date Return of 0.0%. This indicator is about the same for the Energy average (which is currently at 0.0) sector and about the same as Uranium (which currently averages 0.0) industry. This indicator is about the same for all United States stocks average (which is currently at 0.0).
Elevate Year To Date Return Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Elevate Uranium's direct or indirect competition against its Year To Date Return to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of Elevate Uranium could also be used in its relative valuation, which is a method of valuing Elevate Uranium by comparing valuation metrics of similar companies.Elevate Uranium is currently under evaluation in year to date return category among its peers.
Elevate Fundamentals
| Return On Equity | -0.41 | |||
| Return On Asset | -0.24 | |||
| Current Valuation | 59.41 M | |||
| Shares Outstanding | 275.5 M | |||
| Shares Owned By Insiders | 16.66 % | |||
| Shares Owned By Institutions | 10.13 % | |||
| Price To Book | 5.94 X | |||
| Price To Sales | 1,137 X | |||
| Revenue | 116.86 K | |||
| Gross Profit | 116.86 K | |||
| EBITDA | (5.69 M) | |||
| Net Income | (5.73 M) | |||
| Cash And Equivalents | 15.81 M | |||
| Cash Per Share | 0.06 X | |||
| Total Debt | 177.27 K | |||
| Debt To Equity | 0.01 % | |||
| Current Ratio | 23.53 X | |||
| Book Value Per Share | 0.07 X | |||
| Cash Flow From Operations | (4.38 M) | |||
| Earnings Per Share | (0.01) X | |||
| Beta | 1.02 | |||
| Market Capitalization | 84.11 M | |||
| Total Asset | 19.33 M | |||
| Net Asset | 19.33 M |
About Elevate Uranium Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Elevate Uranium's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Elevate Uranium using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Elevate Uranium based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in Elevate OTC Stock
Elevate Uranium financial ratios help investors to determine whether Elevate OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Elevate with respect to the benefits of owning Elevate Uranium security.